Owkin is a French-American artificial intelligence and biotech company that aims to identify new treatments, optimize clinical trials and develop AI diagnostics. The company uses multimodal patient data from academic institutions and hospitals to train its AI models for drug discovery, development, and diagnostics. Owkin has collaborated with pharmaceutical companies around the world to improve their therapeutic programs.
Owkin has received investment from 1 venture capital firm.
Owkin is a French-American artificial intelligence and biotech company that aims to identify new treatments, optimize clinical trials and develop AI diagnostics.
Owkin has received investment from NVIDIA NVentures. These venture capital firms and investors provide both capital and strategic support.
Owkin operates in the Biotech sector. Owkin is a French-American artificial intelligence and biotech company that aims to identify new treatments, optimize clinical trials and develop AI diagnostics.
